Literature DB >> 13315889

The chemical basis of the virulence of Bacillus anthracis. VI. An extracellular immunising aggressin isolated from exudates of infected guinea-pigs.

H SMITH, R C GALLOP.   

Abstract

Entities:  

Keywords:  ANTHRAX/immunology; BACILLUS ANTHRACIS

Mesh：

Year:  1956        PMID： 13315889      PMCID： PMC2082560     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN： 0007-1021


× No keyword cloud information.
  5 in total

1.  Studies on a protective antigen produced in vitro from Bacillus anthracis: purification and chemistry of the antigen.

Authors:  R E STRANGE; F C BELTON
Journal:  Br J Exp Pathol       Date:  1954-04

2.  Studies on a protective antigen produced in vitro from Bacillus anthracis: medium and methods of production.

Authors:  F C BELTON; R E STRANGE
Journal:  Br J Exp Pathol       Date:  1954-04

3.  Studies on immunity in anthrax. III. Elaboration of protective antigen in a chemically defined, non-protein medium.

Authors:  G G WRIGHT; M A HEDBERG; J B SLEIN
Journal:  J Immunol       Date:  1954-04       Impact factor: 5.422

4.  A colorimetric method for the determination of glucosamine and chondrosamine.

Authors:  L A Elson; W T Morgan
Journal:  Biochem J       Date:  1933       Impact factor: 3.857

5.  Influence of sugars and amines on the colorimetric hexosamine method of elson and morgan and its possible elimination.

Authors:  J IMMERS; E VASSEUR
Journal:  Nature       Date:  1950-06-03       Impact factor: 49.962
  5 in total
  10 in total

1.  Melioidosis: pathogenesis and immunity in mice and hamsters. II. Studies with avirulent strains of Malleomyces pseudomallei.

Authors:  A M DANNENBERG; E M SCOTT
Journal:  Am J Pathol       Date:  1958 Nov-Dec       Impact factor: 4.307

2.  The chemical basis of the virulence of Bacillus anthracis. VIII. Fractionation of the intracellular material of Bacillus anthracis.

Authors:  P W HARRIS-SMITH; H SMITH; H T ZWARTOUW
Journal:  Br J Exp Pathol       Date:  1956-08

3.  Immunization studies with attenuated strains of Bacillus anthracis.

Authors:  B E Ivins; J W Ezzell; J Jemski; K W Hedlund; J D Ristroph; S H Leppla
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

4.  Comparative efficacy of Bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in the guinea pig.

Authors:  S F Little; G B Knudson
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

5.  In vivo-produced anthrax toxin.

Authors:  D C Fish; R E Lincoln
Journal:  J Bacteriol       Date:  1968-03       Impact factor: 3.490

Review 6.  Status of bacterial toxins and their nomenclature: need for discipline and clarity of expression.

Authors:  P F Bonventre; R E Lincoln; C Lamanna
Journal:  Bacteriol Rev       Date:  1967-06

7.  Purification and properties of in vitro-produced anthrax toxin components.

Authors:  D C Fish; B G Mahlandt; J P Dobbs; R E Lincoln
Journal:  J Bacteriol       Date:  1968-03       Impact factor: 3.490

8.  Exposure to Bacillus anthracis capsule results in suppression of human monocyte-derived dendritic cells.

Authors:  Tanya M Jelacic; Donald J Chabot; Joel A Bozue; Steven A Tobery; Michael W West; Krishna Moody; De Yang; Joost J Oppenheim; Arthur M Friedlander
Journal:  Infect Immun       Date:  2014-06-02       Impact factor: 3.441

9.  QUANTITATIVE ASSAY FOR CRUDE ANTHRAX TOXINS.

Authors:  B W HAINES; F KLEIN; R E LINCOLN
Journal:  J Bacteriol       Date:  1965-01       Impact factor: 3.490

Review 10.  Recent advances in the development of an improved, human anthrax vaccine.

Authors:  B E Ivins; S L Welkos
Journal:  Eur J Epidemiol       Date:  1988-03       Impact factor: 8.082
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.